5-[4-[(5-methyl-2,4-dioxo-pyrimidin-1-yl)methyl]phenyl]pentanoic Acid | 886836-70-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 5-[4-[(5-methyl-2,4-dioxo-pyrimidin-1-yl)methyl]phenyl]pentanoic Acid
• 英文别名: 5-[4-[(5-methyl-2,4-dioxopyrimidin-1-yl)methyl]phenyl]pentanoic acid
• CAS: 886836-70-0
• 化学式: C₁₇H₂₀N₂O₄
• 分子量: 316.357
• InChiKey: LQAAOAOFFCWKBU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  23
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  86.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  甲醇 、 5-[4-[(5-methyl-2,4-dioxo-pyrimidin-1-yl)methyl]phenyl]pentanoic Acid 在 Dowex 5W (H+) 作用下， 生成 5-[4-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)phenyl]pentanoic acid methyl ester
  参考文献：
  名称：

  Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: Synthesis and in vitro anti-mycobacterial activity

  摘要：

  A series of N(1)-(4-substituted-benzyl)-pyrimidines were synthesized as potential inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis (TMPKmt). Key SAR parameters included the chain length substitution in para position of the benzyl ring, the functional group terminating the alkyl chain, and the substituent on the C-5 pyrimidine ring. Synthesized molecules were assayed against both recombinant enzyme and mycobacteria cultures. The most potent compounds have K(i) values in the micromolar range and an MIC(50) of 50 mu g/mL against Mycobacterium bovis. These results will guide the design of a new generation of lead compounds. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.04.045
• 作为产物：
  描述：

  5-methyl-1-(4-iodobenzyl)-1H-pyrimidine-2,4-dione 、 4-戊烯酸 在 palladium diacetate 、 palladium on activated charcoal 三乙胺 、 三(邻甲基苯基)磷 、 氢气 作用下， 以 乙腈 、 甲醇 为溶剂， 20.0~90.0 ℃ 、500.01 kPa 条件下， 反应 48.0h， 以0.31 g的产率得到5-[4-[(5-methyl-2,4-dioxo-pyrimidin-1-yl)methyl]phenyl]pentanoic Acid
  参考文献：
  名称：

  Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: Synthesis and in vitro anti-mycobacterial activity

  摘要：

  A series of N(1)-(4-substituted-benzyl)-pyrimidines were synthesized as potential inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis (TMPKmt). Key SAR parameters included the chain length substitution in para position of the benzyl ring, the functional group terminating the alkyl chain, and the substituent on the C-5 pyrimidine ring. Synthesized molecules were assayed against both recombinant enzyme and mycobacteria cultures. The most potent compounds have K(i) values in the micromolar range and an MIC(50) of 50 mu g/mL against Mycobacterium bovis. These results will guide the design of a new generation of lead compounds. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.04.045

文献信息

• Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents
  申请人：Munier-Lehmann Helene

  公开号：US20080096907A1

  公开（公告）日：2008-04-24

  Substituted aryl pyrimidyl compounds responding to formula (I) and their use for the preparation of a medicament for the prevention and/or treatment of a pathology caused by a mycobacteria.

  本发明涉及哒嗪苯基取代化合物，其符合以下式子（I），以及其用于制备预防和/或治疗由分枝杆菌引起的病理的药物。
• ARYL PYRIMIDYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, THEIR USE AS ANTIMICROBIAL AGENTS
  申请人：INSTITUT PASTEUR

  公开号：EP1814867A2

  公开（公告）日：2007-08-08
• [EN] NEW ARYL PYRIMIDYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, THEIR USE AS ANTIMICROBIAL AGENTS.<br/>[FR] NOUVEAUX COMPOSES ARYLE-PYRIMIDYLIQUES, COMPOSITIONS PHARMACEUTIQUES A BASE DE CES COMPOSES, ET LEUR UTILISANT COMME ANTIMICROBIENS
  申请人：PASTEUR INSTITUT

  公开号：WO2006048336A2

  公开（公告）日：2006-05-11

  (EN) Substituted aryl pyrimidyl compounds responding to formula (I) and their use for the preparation of a medicament for the prevention and/or treatment of a pathology caused by a mycobacteria.(FR) La présente invention concerne des composés aryle-pyrimidyliques substitués représentés par la formule (I) et leur utilisation pour l'élaboration d'un médicament de prévention et/ou de traitement d'une pathologie d'origine mycobatérienne.
• Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: Synthesis and in vitro anti-mycobacterial activity
  作者：Cécile Gasse、Dominique Douguet、Valérie Huteau、Gilles Marchal、Hélène Munier-Lehmann、Sylvie Pochet

  DOI：10.1016/j.bmc.2008.04.045

  日期：2008.6

  A series of N(1)-(4-substituted-benzyl)-pyrimidines were synthesized as potential inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis (TMPKmt). Key SAR parameters included the chain length substitution in para position of the benzyl ring, the functional group terminating the alkyl chain, and the substituent on the C-5 pyrimidine ring. Synthesized molecules were assayed against both recombinant enzyme and mycobacteria cultures. The most potent compounds have K(i) values in the micromolar range and an MIC(50) of 50 mu g/mL against Mycobacterium bovis. These results will guide the design of a new generation of lead compounds. (C) 2008 Elsevier Ltd. All rights reserved.